Onderneming Jupiter Neurosciences, Inc.
Aandelen
JUNS
US48208B2034
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Rosén
FOU | Founder | 33 | 01-06-15 |
Marshall Hayward
FOU | Founder | 69 | 01-06-15 |
Christer Rosén
CEO | Chief Executive Officer | 72 | 01-06-15 |
Alison D. Silva
PSD | President | 46 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christer Rosén
CEO | Chief Executive Officer | 72 | 01-06-15 |
Marshall Hayward
FOU | Founder | 69 | 01-06-15 |
Director/Board Member | 42 | 08-09-21 | |
John Ditton
BRD | Director/Board Member | 60 | 08-09-21 |
Alison D. Silva
PSD | President | 46 | 01-01-18 |
Holger Weis
BRD | Director/Board Member | 61 | 08-09-21 |
Julie Kampf
BRD | Director/Board Member | 62 | 08-09-21 |
Allison W. Brady
BRD | Director/Board Member | 53 | 08-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 409 935 | 1 331 486 ( 8,114 %) | 0 | 8,114 % |
Bedrijfsgegevens
Jupiter Neurosciences, Inc.
1001 North US Highway 1 Suite 504
33477, Jupiter
+
http://www.jupiterneurosciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,14% | 51,12 mld. | |
-6,54% | 39,4 mld. | |
+36,05% | 38,48 mld. | |
+12,62% | 26,36 mld. | |
-12,11% | 26,22 mld. | |
-13,43% | 20,96 mld. | |
+43,73% | 14,02 mld. | |
+31,81% | 12,49 mld. | |
-4,54% | 11,61 mld. |